Cargando…

Therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare

BACKGROUND: Despite the widespread utilisation of complementary and or alternative medicine (CAM) by breast cancer patients in low-and-middle-income countries, few disclose CAM use to their physicians. OBJECTIVE: This study examines disclosure CAM use among a small sample of women attending a breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Githaiga, Jennifer Nyawira, Swartz, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117458/
https://www.ncbi.nlm.nih.gov/pubmed/37092091
http://dx.doi.org/10.4314/ahs.v22i4.11
_version_ 1785028614395265024
author Githaiga, Jennifer Nyawira
Swartz, Leslie
author_facet Githaiga, Jennifer Nyawira
Swartz, Leslie
author_sort Githaiga, Jennifer Nyawira
collection PubMed
description BACKGROUND: Despite the widespread utilisation of complementary and or alternative medicine (CAM) by breast cancer patients in low-and-middle-income countries, few disclose CAM use to their physicians. OBJECTIVE: This study examines disclosure CAM use among a small sample of women attending a breast cancer clinic in a public health hospital in the Western Cape, South Africa. METHODS: An Interpretative Phenomenological Analysis (IPA) approach was utilised in this study. Semi-structured in-depth interviews were conducted with a convenience sample of 17 women attending a breast clinic in a public hospital. RESULTS: Non-disclosure of CAM use was attributed to minimal time for patient-doctor interactions due to resource constraints in public health facilities and the superior status accorded to biomedical doctors' superior knowledge, associated with paternalism, leading to patients' fear of reproach for using CAM. Consequently, disclosure of CAM only occurred in instances where it was deemed an absolute necessity. CONCLUSION: Considering the reality of an overstretched public healthcare system, what may be possible is an active attempt to communicate to patients that doctors are aware that patients may use a range of resources (such as CAM), which is their right, and further, recommend patient disclosure of CAM use to their doctors, because of the possibility of drug interactions and other potentially negative effects.
format Online
Article
Text
id pubmed-10117458
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Makerere Medical School
record_format MEDLINE/PubMed
spelling pubmed-101174582023-04-21 Therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare Githaiga, Jennifer Nyawira Swartz, Leslie Afr Health Sci Articles BACKGROUND: Despite the widespread utilisation of complementary and or alternative medicine (CAM) by breast cancer patients in low-and-middle-income countries, few disclose CAM use to their physicians. OBJECTIVE: This study examines disclosure CAM use among a small sample of women attending a breast cancer clinic in a public health hospital in the Western Cape, South Africa. METHODS: An Interpretative Phenomenological Analysis (IPA) approach was utilised in this study. Semi-structured in-depth interviews were conducted with a convenience sample of 17 women attending a breast clinic in a public hospital. RESULTS: Non-disclosure of CAM use was attributed to minimal time for patient-doctor interactions due to resource constraints in public health facilities and the superior status accorded to biomedical doctors' superior knowledge, associated with paternalism, leading to patients' fear of reproach for using CAM. Consequently, disclosure of CAM only occurred in instances where it was deemed an absolute necessity. CONCLUSION: Considering the reality of an overstretched public healthcare system, what may be possible is an active attempt to communicate to patients that doctors are aware that patients may use a range of resources (such as CAM), which is their right, and further, recommend patient disclosure of CAM use to their doctors, because of the possibility of drug interactions and other potentially negative effects. Makerere Medical School 2022-12 /pmc/articles/PMC10117458/ /pubmed/37092091 http://dx.doi.org/10.4314/ahs.v22i4.11 Text en © 2022 Githaiga JN et al. https://creativecommons.org/licenses/by/4.0/Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Githaiga, Jennifer Nyawira
Swartz, Leslie
Therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare
title Therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare
title_full Therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare
title_fullStr Therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare
title_full_unstemmed Therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare
title_short Therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare
title_sort therapeutic pluralism and the politics of disclosure: breast cancer patients' experiences in public healthcare
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117458/
https://www.ncbi.nlm.nih.gov/pubmed/37092091
http://dx.doi.org/10.4314/ahs.v22i4.11
work_keys_str_mv AT githaigajennifernyawira therapeuticpluralismandthepoliticsofdisclosurebreastcancerpatientsexperiencesinpublichealthcare
AT swartzleslie therapeuticpluralismandthepoliticsofdisclosurebreastcancerpatientsexperiencesinpublichealthcare